STAT3 and cancer: Second, it functions as a direct STAT3i with proven STAT3-related therapeutic activity in cancer patients with advanced systemic disease when used orally as part of bioavailable formulations accompanied by low toxicity and reversible mild side-effects [23,24,25,26] (Figure 3).